Target intelligence / Profile preview

Venturia inaequalis messenger RNA (V. inaequalis mRNA)

Target
V. inaequalis mRNA
Molecular classification
Nucleic acid, Other
01

Overview

Venturia inaequalis messenger RNA (mRNA) refers to the collective set of protein-coding transcripts produced by the ascomycete fungus responsible for apple scab, one of the most economically significant diseases in global apple production (Source: Wikipedia). In the context of modern agricultural biotechnology, specific mRNA sequences within this pathogen are targeted using Spray-Induced Gene Silencing (SIGS), a form of RNA interference (RNAi) (Source: Frontiers in Plant Science, 2021). This approach involves the application of double-stranded RNA (dsRNA) molecules designed to be sequence-specific to essential fungal genes, such as those encoding lanosterol 14α-demethylase (CYP51) or chitin synthases (Source: Pest Management Science, 2023). Once the fungus takes up these dsRNA molecules, its internal RNAi machinery processes them into small interfering RNAs (siRNAs) that guide the degradation of the target mRNA (Source: Molecular Plant Pathology, 2020). The resulting loss of mRNA prevents the translation of proteins necessary for fungal survival, growth, and infection of the host plant (Source: Plants, 2022). While RNAi-based fungicides represent a highly specific and potentially sustainable alternative to traditional chemical treatments, their commercial success depends on overcoming challenges such as RNA stability in the environment and ensuring no off-target effects occur in beneficial organisms (Source: Journal of Fungi, 2021).

Other names
Apple scab mRNAVenturia inaequalis transcriptomeV. inaequalis RNA transcripts
02

Mechanism of action

RNA interference (RNAi) leading to sequence-specific degradation of fungal mRNA and subsequent gene silencing.

03

Biological functions

Protein synthesisGenetic information transferOther
04

Disease associations

Infection
05

Safety considerations

Off-target effects on non-target speciesEnvironmental degradation of RNAPotential for resistance development
06

Interacting drugs

Double-stranded RNA (dsRNA)

1 more in the full profile.

07

Biomarkers

mRNA expression levelsFungal biomassSpore germination rate

Beyond the preview

Go deeper on Venturia inaequalis messenger RNA (V. inaequalis mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Venturia inaequalis messenger RNA (V. inaequalis mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call